Skip to main content
. 2017 Nov 10;29(2):341–346. doi: 10.1093/annonc/mdx731

Table 2.

Comparison of survival outcomes between the IGCCCG, IU and NCI SEER dataset

Risk per IGCCCG criteria 5-Year Indiana University 1998–2014 (%) IGCCCG 1975–1990 (%) NCI SEER 2000–2013 (%)
Good risk PFS 90 88 NA
OS 97 91
Intermediate risk PFS 84 75 NA
OS 92 79
Poor risk PFS 54 41 NA
OS 73 48
Testis cancer cohort OS 94 NA 75

IGCCCG, International Germ Cell Cancer Collaborative Group; PFS, progression-free survival; OS, overall survival, NCI SEER: National Cancer Institute Surveillance, Epidemiology, and End Results Program.